Angel Biotechnology Holdings (LSE:ABH) Total Liabilities: £2.60 Mil (As of Sep. 2012)


What is Angel Biotechnology Holdings Total Liabilities?

Angel Biotechnology Holdings LSE:ABH Total Liabilities is £2.60 Mil as of Sep. 2012. The stock has 2 warning signs investors should review.

Angel Biotechnology Holdings's Total Liabilities for the quarter that ended in Sep. 2012 was £2.60 Mil.

Angel Biotechnology Holdings's quarterly Total Liabilities increased from Jun. 2011 (£0.27 Mil) to Mar. 2012 (£0.90 Mil) and increased from Mar. 2012 (£0.90 Mil) to Sep. 2012 (£2.60 Mil).

Angel Biotechnology Holdings's annual Total Liabilities declined from Dec. 2009 (£2.25 Mil) to Dec. 2010 (£1.49 Mil) and declined from Dec. 2010 (£1.49 Mil) to Mar. 2012 (£0.90 Mil).

Angel Biotechnology Holdings Total Liabilities Historical Data

* Premium members only.

The historical data trend for Angel Biotechnology Holdings's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Angel Biotechnology Holdings Total Liabilities Chart

Angel Biotechnology Holdings Annual Data
Trend Dec02 Dec03 Dec04 Dec05 Dec07 Dec08 Dec09 Dec10 Mar12
Total Liabilities
Get a 7-Day Free Trial Premium Member Only 0.97 1.58 2.25 1.49 0.90

Angel Biotechnology Holdings Semi-Annual Data
Jun05 Dec05 Jun06 Jun07 Dec07 Jun08 Dec08 Jun09 Dec09 Jun10 Dec10 Jun11 Mar12 Sep12
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.78 1.49 0.27 0.90 2.60

Angel Biotechnology Holdings Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Angel Biotechnology Holdings's Total Liabilities for the fiscal year that ended in Mar. 2012 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=0.76+(0+0.135
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=0.90

Total Liabilities=Total Assets (A: Mar. 2012 )-Total Equity (A: Mar. 2012 )
=2.699-1.804
=0.90

Angel Biotechnology Holdings's Total Liabilities for the quarter that ended in Sep. 2012 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=2.464+(0+0.135
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=2.60

Total Liabilities=Total Assets (Q: Sep. 2012 )-Total Equity (Q: Sep. 2012 )
=2.482--0.117
=2.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of £2.60 Mil mean?
Angel Biotechnology Holdings (LSE:ABH) has a Total Liabilities of £2.60 Mil as of Sep. 2012. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Angel Biotechnology Holdings and its competitors.
Is Angel Biotechnology Holdings' Total Liabilities too high?
Angel Biotechnology Holdings' current Total Liabilities is £2.60 Mil.
How does Angel Biotechnology Holdings' Total Liabilities compare to competitors?
Angel Biotechnology Holdings' Total Liabilities of £2.60 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Angel Biotechnology Holdings and its competitors. Angel Biotechnology Holdings's current Total Liabilities is £2.60 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Angel Biotechnology Holdings stock overvalued right now?
Angel Biotechnology Holdings (LSE:ABH) has a current Total Liabilities of £2.60 Mil. The current Total Liabilities is £2.60 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Angel Biotechnology Holdings (LSE:ABH), the current Total Liabilities is £2.60 Mil as of Sep. 2012. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.